title: How much money is spent on vaccines across Western European countries?
abstract: Prevention programs, particularly vaccinations, remain highly vulnerable to budget cuts because their benefits may not be immediately identifiable. Seven Western European countries were selected (Germany, England, France, Italy, Spain, Sweden and Portugal) constituting a good mix of vaccine procurement modalities, with the objective to document the proportion of healthcare spending devoted to vaccines and its evolution. A data search was performed using the OECD online databases and official national sources from 2008 (2006 for England). No country spent more than 0.5% of its healthcare budget on vaccines. The proportion ranged from 0.25% in Spain (2012) and France (2013) to 0.47% in Germany (2014). Whereas healthcare spending increased in all countries but Spain (with increases ranging from +2.6% per year in France between 2008 and 2013 to +8.1% per year in England between 2006/07 and 2009/10), vaccine spending diminished markedly in Germany (-6.2% per year from 2008 to 2014), Spain (-6.7% per year from 2008 to 2012) and France (-4.2% per year from 2008 to 2013). Only Sweden (+5.9% per year from 2011 to 2013) and England (+18.9% per year from 2006/07 to 2009/10) increased their spending on vaccines. Vaccination involves relatively low levels of healthcare investment in Western Europe relative to the far-reaching public health benefits that it provides. We found a net trend toward a decrease in such spending in recent years, with the exception of Sweden and England. Vaccination budgets should be preserved or even increased to sustain a life-course approach to immunization with sufficient coverage rates.
authors.affiliation: a Department of Public Health Sciences , Faculty of Medicine, University of Liège , Liège , Belgium.|b SERFAN Innovation , Namur , Belgium.
authors.forename: Olivier
authors.initials: O
authors.lastname: Ethgen
authors.affiliation: c Sanofi Pasteur MSD , Lyon , France.
authors.forename: Florence
authors.initials: F
authors.lastname: Baron-Papillon
authors.affiliation: c Sanofi Pasteur MSD , Lyon , France.
authors.forename: Murielle
authors.initials: M
authors.lastname: Cornier
mesh_terms: D055808:Drug Discovery / Q000191:economics*; D005060:Europe; D005102:Health Expenditures; D006801:Humans; D017589:Immunization Programs / Q000191:economics*; D014612:Vaccines / Q000008:administration & dosage* / Q000302:isolation & purification*
chemical_list: D014612:Vaccines
keywords: Western Europe; budget; prevention; spending; vaccines